Cargando…
Construction of an immune-related signature with prognostic value for colon cancer
BACKGROUND: Colon cancer is the third most common malignant tumor in the world. Although immunotherapy has been used in cancer treatment, there is still no first-line immunotherapy method for colon cancer. Therefore, it is essential to search for potential immunotherapy targets and molecular biomark...
Autores principales: | Lv, Yunxia, Wang, Xinyi, Ren, Yu, Fu, Xiaorui, Li, Taiyuan, Jiang, Qunguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106397/ https://www.ncbi.nlm.nih.gov/pubmed/33996273 http://dx.doi.org/10.7717/peerj.10812 |
Ejemplares similares
-
A 7-lncRNA signature associated with the prognosis of colon adenocarcinoma
por: Fu, Xiaorui, et al.
Publicado: (2020) -
Identifying a new microRNA signature as a prognostic biomarker in colon cancer
por: Lv, Yunxia, et al.
Publicado: (2020) -
Analyzing and validating the prognostic value and mechanism of colon cancer immune microenvironment
por: Wang, Xinyi, et al.
Publicado: (2020) -
Analysis of multi-omics differences in left-side and right-side colon cancer
por: Huang, Yanyi, et al.
Publicado: (2021) -
KRAS mutations are negatively correlated with immunity in colon cancer
por: Fu, Xiaorui, et al.
Publicado: (2020)